Schedule 13G ownership disclosure

AEON Biopharma, Inc.

Common Stock, $.0001 par value · CUSIP: 00791X100

Event date: 2025-01-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIGGER CAPITAL FUND L P

    Shares: 2,450,000.00 · Class: 3.1%

  • Bigger Capital Fund GP, LLC

    Shares: 2,450,000.00 · Class: 3.1%

  • District 2 Capital Fund LP

    Shares: 2,450,000.00 · Class: 3.1%

  • District 2 Capital LP

    Shares: 2,450,000.00 · Class: 3.1%

  • District 2 GP LLC

    Shares: 2,450,000.00 · Class: 3.1%

  • District 2 Holdings LLC

    Shares: 2,450,000.00 · Class: 3.1%

  • Bigger Michael

    Shares: 4,900,000.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-000092
Form type
SCHEDULE 13G
Filer
AEON Biopharma, Inc.
CIK
CIK 1837607
Filed
Jan 08, 2025
Reporting period
Jan 06, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub